Allurion Technologies (ALUR) Share-based Compensation (2022 - 2026)
Allurion Technologies (ALUR) posted Share-based Compensation of $1.0 million for Q1 2026, up 42.45% on a QoQ basis from $702000.0 in Q4 2025, and up 11.48% year-over-year from $897000.0 in Q1 2025.
Allurion Technologies (ALUR) Share-based Compensation (2022 - 2026) Analysis & Trends
Allurion Technologies' Share-based Compensation history runs 5 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Share-based Compensation rose 11.48% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 70.6% YoY) and the FY2025 annual result came in at $3.1 million, up 2.95% from the prior year.
- Share-based Compensation was $1.0 million for Q1 2026 at Allurion Technologies, up from $702000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $5.5 million in Q3 2023 and bottomed at $89000.0 in Q2 2022.
- A 5-year average of $995187.5 and a median of $753500.0 in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2023 — Share-based Compensation jumped 5855.91% — and 2024, when it tumbled 84.47%.
- Allurion Technologies' Share-based Compensation stood at $182000.0 in 2022, then jumped by 1003.3% to $2.0 million in 2023, then tumbled by 58.22% to $839000.0 in 2024, then retreated by 16.33% to $702000.0 in 2025, then soared by 42.45% to $1.0 million in 2026.
- Business Quant data shows ALUR's Share-based Compensation at $1.0 million in Q1 2026, $702000.0 in Q4 2025, and $531000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 702,000.00 |
| Dec 31, 2025 | 702,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Sep 30, 2025 | 531,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 897,000.00 |
| Mar 31, 2025 | 897,000.00 |
| Dec 31, 2024 | 839,000.00 |
| Dec 31, 2024 | 839,000.00 |
| Sep 30, 2024 | 860,000.00 |
| Sep 30, 2024 | 860,000.00 |
| Jun 30, 2024 | 805,000.00 |
| Jun 30, 2024 | 805,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Mar 31, 2024 | 552,000.00 |
| Dec 31, 2023 | 2.01 Mn |
| Dec 31, 2023 | 2.01 Mn |